Walleye Capital LLC Nkarta, Inc. Transaction History

Walleye Capital LLC

  • $38.9 Billion
  • Q4 2024

A detailed history of Walleye Capital LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 73,387 shares of NKTX stock, worth $146,774. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,387
Holding current value
$146,774
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$2.17 - $4.34 $159,249 - $318,499
73,387 New
73,387 $182,000
Q1 2024

May 15, 2024
BUY
$5.59 - $15.71 $693,825 - $1.95 Million
124,119 New
124,119 $1.34 Million
Q2 2022

Aug 08, 2022
SELL
$7.77 - $19.44 $358,064 - $895,853
-46,083 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$8.66 - $14.99 $138,308 - $239,405
15,971 Added 53.04%
46,083 $524,000
Q4 2021

Mar 03, 2022
BUY
$12.79 - $26.88 $385,132 - $809,410
30,112 New
30,112 $462,000

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $97.3M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email